IP Verse

Novel Compounds Having Inhibitory Activity Against Sodium Dependant Glucose Transporter - EP2896397

PATENT ANALYSIS

Patent Details

Grant Date
Oct 7, 2020
Company
MITSUBISHI TANABE PHARMA CORPORATION
Oppositions

GALENICUM HEALTH S.L.

GENERICS (UK) LTD

More patents of Mitsubishi Tanabe Pharma Corporation

EP2896397

EP2252289

EP2754440

Want to monitor this patent?

Feel free to send us a message here and we will get back to you